What is BPC 157, and how does it work in the body
Tirzepatide is a first-in-class dual incretin receptor agonist a single molecule that activates both the GIP (glucose-dependent insulinotropic polypeptide) and the GLP-1 (glucagon-like peptide-1) receptors, which is why it is often nicknamed a twincretin. [7] By engaging two incretin pathways it enhances glucose-dependent insulin secretion, promotes satiety, and delays gastric emptying, producing large effects on both glycemic control and bodyweight
This can help reduce the appearance of wrinkles and fine lines, making it a popular choice for those seeking aesthetic improvements
There are anecdotal reports of adverse effects such as injection site pain, anxiety, insomnia, headaches, dizziness, and gastrointestinal discomfort, but these are not well-documented in clinical studies
The safety profile of sublingual peptides depends primarily on the specific peptide being administered rather than the delivery route
doi: 10.3748/wjg.v20.i21.6386 2 HooiJKYLaiWYNgWKSuenMMYUnderwoodFETanyingohDet al